Revelation Biosciences Inc. (REVB) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Revelation Biosciences In...

    NASDAQ: REVB · Real-Time Price · USD
    1.42
    0.02 (1.43%)
    At close: Sep 26, 2025, 1:16 PM

    Revelation Biosciences Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 27.92K 25.05K 40.01K 69.17K
    Gross Profit
    		 -27.92K -25.05K -40.01K -69.17K
    Operating Income
    		 -7.97M -8.66M -10.87M -11.95M
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 -15.04M -120K -10.83M -11.99M
    Net Income
    		 -15.04M -120K -10.83M -11.99M
    Selling & General & Admin
    		 4.43M 4.51M 5.49M 5.04M
    Research & Development
    		 3.55M 4.15M 5.38M 6.92M
    Other Expenses
    		 n/a n/a 1K -1K
    Operating Expenses
    		 7.97M 8.66M 10.87M 11.95M
    Interest Expense
    		 n/a n/a n/a 41.76K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 7.97M 8.66M 10.87M 11.95M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 171.51K 14.29K 1.12K 587.58
    Shares Outstanding (Diluted)
    		 171.51K 14.29K 1.12K 587.58
    EPS (Basic)
    		 -87.68 -8.41 -9.64K -20.4K
    EPS (Diluted)
    		 -87.68 -8.41 -9.64K -20.4K
    EBITDA
    		 -7.95M -8.63M -10.84M -11.93M
    EBIT
    		 -7.97M -8.66M -10.87M -11.95M
    Depreciation & Amortization
    		 27.92K 25.05K 25.05K 16.78K

    Add to Watchlist